{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:56:13Z","timestamp":1790834173919,"version":"4.1.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"SI","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Scleroderma Australia, Arthritis Australia, Actelion Australia"},{"DOI":"10.13039\/501100001203","name":"GlaxoSmithKline Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001203","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1197169"],"award-info":[{"award-number":["APP1197169"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Arthritis Australia Australian Rheumatology Association\u2014Victoria","award":["GTN1176538"],"award-info":[{"award-number":["GTN1176538"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The objective of this study was to identify those SSc patients with concurrent pulmonary hypertension (PH) (SSc-PH patients) and interstitial lung disease (ILD) and determine their disease severity, therapeutic approach, and survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Consecutive SSc patients enrolled in the Australian Scleroderma Cohort Study (ASCS) who were diagnosed with pulmonary hypertension (via right-heart catherization) were included in the study. Logistic regression was used to determine the associations of ILD with PH hemodynamic parameters and therapeutic approach. Kaplan\u2013Meier survival curves were used to estimate survival rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 1883 SSc patients, 164 (8.7%) developed incident PH over a median follow-up of 4.3 (1.7\u20137.9) years. Of these, 43.9% had concurrent ILD at PH diagnosis (PH-ILD) and 56.1% had group 1 pulmonary arterial hypertension (PAH). Extensive ILD was present at PH diagnosis in 40.3%. Despite these distinct PH cohorts, a similar frequency of each PH cohort was treated with vasodilatory therapy at PH diagnosis, regardless of the presence or severity of ILD. The majority (87.5%) of those patients with extensive ILD and PH received upfront vasodilatory therapy at PH diagnosis, with no difference in its tolerability or therapy cessation being observed compared with the patients with group 1 PAH. Although vasodilator therapy was not associated with a survival advantage in those with extensive ILD, its use was associated with an amelioration of symptoms, and an improvement in physical function, and quality of life (QoL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite vasodilator therapy, survival in SSc-PH was found to be poor, with the presence of concurrent ILD being associated with worse survival. Although vasodilator therapy commenced at PH diagnosis was not shown to be associated with an improved survival in PH with extensive ILD, it appeared to be well tolerated and may improve symptoms, physical function, and QoL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae166","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T18:26:06Z","timestamp":1710181566000},"page":"SI140-SI148","source":"Crossref","is-referenced-by-count":8,"title":["Predictors and prognosis of pulmonary hypertension complicating interstitial lung disease in systemic sclerosis"],"prefix":"10.1093","volume":"64","author":[{"given":"Kathleen","family":"Morrisroe","sequence":"first","affiliation":[{"name":"Department of Medicine, The University of Melbourne at St Vincent\u2019s Hospital , Melbourne, Victoria,","place":["Australia"]},{"name":"Department of Rheumatology, St Vincent\u2019s Hospital , Melbourne, Victoria,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, St Vincent\u2019s Hospital , Melbourne, Victoria,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stevens","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, St Vincent\u2019s Hospital , Melbourne, Victoria,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4636-729X","authenticated-orcid":false,"given":"Laura","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Melbourne at St Vincent\u2019s Hospital , Melbourne, Victoria,","place":["Australia"]},{"name":"Department of Rheumatology, St Vincent\u2019s Hospital , Melbourne, Victoria,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Sahhar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Monash University, Clayton and Monash Health , Melbourne, Victoria,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene-Siew","family":"Ngian","sequence":"additional","affiliation":[{"name":"Department of Medicine, Monash University, Clayton and Monash Health , Melbourne, Victoria,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hill","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Royal Adelaide Hospital , Adelaide, South Australia,","place":["Australia"]},{"name":"Rheumatology Unit, The Queen Elizabeth Hospital , Woodville, South Australia,","place":["Australia"]},{"name":"Discipline of Medicine, University of Adelaide , Adelaide, South Australia,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Host","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal Perth Hospital , Perth,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Walker","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Flinders Medical Centre , Adelaide, South Australia,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Proudman","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Royal Adelaide Hospital , Adelaide, South Australia,","place":["Australia"]},{"name":"Discipline of Medicine, University of Adelaide , Adelaide, South Australia,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Melbourne at St Vincent\u2019s Hospital , Melbourne, Victoria,","place":["Australia"]},{"name":"Department of Rheumatology, St Vincent\u2019s Hospital , Melbourne, Victoria,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"key":"2025121017315667200_keae166-B1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.semarthrit.2007.05.003","article-title":"Incidence and prevalence of systemic sclerosis: a systematic literature review","volume":"37","author":"Chifflot","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"2025121017315667200_keae166-B2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/art.22910","article-title":"Depression in patients with systemic sclerosis: a systematic review of the evidence","volume":"57","author":"Thombs","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2025121017315667200_keae166-B3","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.40027","article-title":"Early mortality in a multinational systemic sclerosis inception cohort","volume":"69","author":"Hao","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025121017315667200_keae166-B4","doi-asserted-by":"crossref","first-page":"e8503","DOI":"10.1097\/MD.0000000000008503","article-title":"Quantifying the direct public health care cost of systemic sclerosis: a comprehensive data linkage study","volume":"96","author":"Morrisroe","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl 100","key":"2025121017315667200_keae166-B5","first-page":"79","article-title":"Determinants of unemployment amongst Australian systemic sclerosis patients: results from a multicentre cohort study","volume":"34","author":"Morrisroe","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2025121017315667200_keae166-B6","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/jamacardio.2016.3591","article-title":"Trends and outcomes of pulmonary arterial hypertension-related hospitalizations in the United States: analysis of the nationwide inpatient sample database from 2001 through 2012","volume":"1","author":"Anand","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2025121017315667200_keae166-B7","doi-asserted-by":"crossref","first-page":"170056","DOI":"10.1183\/16000617.0056-2017","article-title":"Pulmonary hypertension in systemic sclerosis: different phenotypes","volume":"26","author":"Launay","year":"2017","journal-title":"Eur Respir Rev"},{"key":"2025121017315667200_keae166-B8","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"2025121017315667200_keae166-B9","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2025121017315667200_keae166-B10","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s10067-013-2307-2","article-title":"Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature","volume":"32","author":"Yang","year":"2013","journal-title":"Clin Rheumatol"},{"key":"2025121017315667200_keae166-B11","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","article-title":"Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach","volume":"62","author":"Mukerjee","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"2025121017315667200_keae166-B12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13075-017-1341-x","article-title":"Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension","volume":"19","author":"Morrisroe","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2025121017315667200_keae166-B13","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/art.40862","article-title":"Prevalence, treatment, and outcomes of coexistent pulmonary hypertension and interstitial lung disease in systemic sclerosis","volume":"71","author":"Young","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2025121017315667200_keae166-B14","first-page":"S-109","article-title":"Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters","volume":"32","author":"Fischer","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2025121017315667200_keae166-B15","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension","volume":"373","author":"Gali\u00e8","year":"2015","journal-title":"New England Journal of Medicine"},{"key":"2025121017315667200_keae166-B16","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2025121017315667200_keae166-B17","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 11","key":"2025121017315667200_keae166-B18","first-page":"S98","article-title":"Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), Physician- and Patient-Rated Global Assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS)","volume":"63","author":"Pope","year":"2011","journal-title":"Arthritis Care Res"},{"key":"2025121017315667200_keae166-B19","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1038\/s41598-022-09353-z","article-title":"Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension","volume":"12","author":"Guill\u00e9n-Del-Castillo","year":"2022","journal-title":"Sci Rep"},{"key":"2025121017315667200_keae166-B20","first-page":"2398","article-title":"Scleroderma patients with combined pulmonary hypertension and interstitial lung disease","volume":"30","author":"Chang","year":"2003","journal-title":"J Rheumatol"},{"key":"2025121017315667200_keae166-B21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.24267","article-title":"Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease","volume":"60","author":"Mathai","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2025121017315667200_keae166-B22","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1164\/rccm.200909-1331PP","article-title":"Systemic sclerosis-associated pulmonary arterial hypertension","volume":"181","author":"Le Pavec","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2025121017315667200_keae166-B23","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/CIRCRESAHA.121.319970","article-title":"Group 3 Pulmonary Hypertension: from Bench to Bedside","volume":"130","author":"Singh","year":"2022","journal-title":"Circ Res"},{"key":"2025121017315667200_keae166-B24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/art.41512","article-title":"Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease","volume":"73","author":"Chauvelot","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2025121017315667200_keae166-B25","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/art.38623","article-title":"Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease","volume":"66","author":"Volkmann","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025121017315667200_keae166-B26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.24267","article-title":"Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease","volume":"60","author":"Mathai","year":"2009","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae166\/57362144\/keae166.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/SI\/SI140\/57362144\/keae166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/SI\/SI140\/57362144\/keae166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T22:32:12Z","timestamp":1765405932000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/SI\/SI140\/7627405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":26,"journal-issue":{"issue":"SI","published-online":{"date-parts":[[2024,3,12]]},"published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae166","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2024,3,12]]}}}